陕西麦科奥特科技有限公司 Alternatives & Competitors

12 companies similar to 陕西麦科奥特科技有限公司 — 麦科奥特成立于2007年，是一群以“挽救生命、减轻病痛”为使命、以”创制一线抢救和治疗...

Concortis Biosystems Corp

Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduc...

San Diego, United States

Biotechnology Health Care +1

Retrotope

Pioneering a novel drug platform to safeguard and rejuvenate mitochondrial health in degen...

Series D $82.73M

Biotechnology Health Care

Antlia Bioscience, Inc.

Turning promising peptides into groundbreaking therapeutics for chronic diseases

Encinitas, United States

Biotechnology Health Care

VG Life Sciences

Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...

Post-IPO Equity $2.79M

Biotechnology Health Care

Track all 陕西麦科奥特科技有限公司 competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Structure Therapeutics

Developing accessible oral small molecule therapies for the treatment of chronic diseases...

219 IPO $1.79B

South San Francisco, Unit...

Biotechnology Health Care +1

ABIONYX Pharma

A New Generation Biotech Company

8 Grant $140.00M

Balma, France

Biotechnology Health Care

RedHill Biopharma Ltd.

RedHill (NASDAQ: RDHL): a pharmaceutical company focused on proprietary drugs for GI and i...

55 Post-IPO Equity $92.95M

Raleigh, United States

Biotechnology Health Care +1

Peptron, Inc.

Revolutionizing Patient Care via "Cozy-Cure": Better Treatments, Enhanced Patient Lives

20 Venture round

Daejeon, Korea South

Biotechnology Health Care +1

Gan & Lee Pharmaceuticals

Science & Excellence

379 Private Equity $46.46M

China

Biopharma Biotechnology +2

Orbit Discovery

Delivering Peptide Enabled Drug Discovery Solutions

31 Seed $13.23M

Oxford, United Kingdom

Biotechnology Health Care +1

MediQuest Therapeutics

Pioneering innovative topical treatments for inflammatory and infectious diseases through...

Venture round $44.78M

Biotechnology Health Care +1

ImmunAbs Inc.

ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope f...

11 Series B

Biotechnology Health Care +1

About 陕西麦科奥特科技有限公司

麦科奥特科技有限公司是一家面向世界的制药公司，我们致力于成为双功能和多功能特异性多肽新分子实体药物研发，成为多肽新药细分领域No.1，心血管创新药物No.1。公司以全球视野下的创新药物研发为战略，以“挽救生命，减轻病痛”为使命，创制一线抢救和治疗药物，满足未被满足的临床需求为己任，专注于心血管、代谢性疾病等致死性重大疾病新药的...

Taxonomy

Pharmaceuticals, Biopharmaceuticals, Drug Development, Peptide Drugs, Innovation, Clinical Research, Biomedical Technology, Cardiovascular Diseases, Neurological Diseases, Biomedical Research, Biomedical Delivery Systems, Metabolic Diseases, Global Operations, Biomedical Production

Frequently Asked Questions

Companies similar to 陕西麦科奥特科技有限公司 include Concortis Biosystems Corp, Retrotope, Antlia Bioscience, Inc., VG Life Sciences, Structure Therapeutics. They work in Health Care and share 陕西麦科奥特科技有限公司's focus on pharmaceuticals, drug development and innovation.

Bounce Watch lists 12 companies that share 陕西麦科奥特科技有限公司's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches 陕西麦科奥特科技有限公司 and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

陕西麦科奥特科技有限公司 Profile Concortis Biosystems Corp Alternatives Retrotope Alternatives Antlia Bioscience, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at 陕西麦科奥特科技有限公司 on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.